ctrl K

Watchlist Price Alert

Talaris Therapeutics Inc. (TALS)

NASDAQ: TALS · Real-Time Price · USD

2.72

-0.02 (-0.73%)

At close: Oct 19, 2023, 8:00 PM

Talaris Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	13.67M	18.61M	17.59M	38.98M
Short-Term Investments	167.61M	225.36M	131.9M	n/a
Long-Term Investments	n/a	n/a	n/a	n/a
Other Long-Term Assets	111K	104K	14K	20K
Receivables	n/a	n/a	374K	n/a
Inventory	n/a	n/a	813K	n/a
Other Current Assets	4.33M	2.54M	76K	39K
Total Current Assets	185.61M	246.51M	150.75M	40.79M
Property-Plant & Equipment	7.99M	4.8M	2.01M	1.13M
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	8.1M	4.91M	2.03M	1.15M
Total Assets	193.72M	251.42M	152.78M	41.94M
Account Payables	3.89M	2.56M	767K	667K
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	910K	n/a	n/a	n/a
Other Current Liabilities	6.67M	5.43M	2.64M	1.62M
Total Current Liabilities	11.46M	7.99M	3.4M	2.29M
Long-Term Debt	1.97M	n/a	n/a	n/a
Other Long-Term Liabilities	224K	626K	1.37M	56.75M
Total Long-Term Liabilities	2.2M	626K	1.37M	56.75M
Total Liabilities	13.66M	8.61M	4.77M	59.04M
Total Debt	2.88M	n/a	n/a	n/a
Common Stock	4K	4K	3K	1K
Retained Earnings	-164.74M	-90.85M	-43.01M	-20.31M
Comprehensive Income	-721K	-78K	-13K	n/a
Shareholders Equity	180.06M	242.81M	148M	-17.1M
Total Investments	167.61M	225.36M	131.9M	n/a